A Case of Chronic Recurrent Multifocal Osteomyelitis (CRMO)
Anjali Alamshaw1, Lori Zadoorian1, Makayla Carlson2
1Pediatrics, Western University of Health Sciences, Pomona, USA.
Insights
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare inflammatory bone disease in children. Early recognition is crucial for timely treatment with NSAIDs or bisphosphonates.
Area of Science:
- Pediatric Rheumatology
- Pediatric Osteology
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, severe inflammatory bone condition predominantly affecting children.
- It presents with bone pain, often in long bones, clavicles, or vertebrae, but can manifest in any bone with varied symptoms, including extraosseous manifestations.
Observation:
- CRMO is a sterile bone disease without an infectious etiology.
- Pathogenesis involves innate immune system dysregulation, including cytokine and inflammasome upregulation, and altered osteoclastic activity.
Findings:
- Diagnostic methods are nonspecific, including imaging (X-ray, MRI), bone biopsy, and inflammatory/autoimmune markers.
- CRMO is a diagnosis of exclusion, often requiring a high index of suspicion.
Implications:
- First-line treatment involves NSAIDs; bisphosphonates are indicated for vertebral involvement.
- This case highlights the importance of considering CRMO in the differential diagnosis of pediatric multifocal bone pain.
Abstract:
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare but underdiagnosed, severe inflammatory bone disease that primarily affects children. It's typically characterized by bone pain, especially within the metaphysis of long bones, clavicles, and vertebrae, but it can present in any bone and with varied presentation, including extraosseous symptoms that may be associated with other autoimmune/inflammatory diseases. Chronic recurrent multifocal osteomyelitis is a sterile bone disease that does not typically have an infectious source. Its pathogenesis involves the dysregulation of the innate immune system via upregulation of cytokines, inflammasomes, and osteoclastic properties. Diagnostic testing is nonspecific and includes X-ray and MRI, bone biopsy, inflammatory markers, and autoimmune markers. Chronic recurrent multifocal osteomyelitis is established by the diagnosis of exclusion. First-line treatment is nonsteroidal anti-inflammatory drugs (NSAIDs); if vertebral involvement is present, a bisphosphonate is typically added. This case report emphasizes the importance of considering CRMO as a differential diagnosis of multifocal bone pain in children.
More Related Videos
09:09Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Related Concept Videos
Osteoclasts in Bone Remodeling
Methods of Documentation II: POMR
Cardiomyopathy IV: Restrictive Cardiomyopathy
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis II: Pathophysiology
